Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines - PubMed (original) (raw)
. 2002 Nov 15;95(10):2243-51.
doi: 10.1002/cncr.10906.
Affiliations
- PMID: 12412180
- DOI: 10.1002/cncr.10906
Free article
Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines
Kaname Yoshizawa et al. Cancer. 2002.
Free article
Abstract
Background: Ligand activation of peroxisome proliferator-activated receptor gamma (PPARgamma) results in the inhibition of proliferation of various cancer cells. The aim of this study is to investigate the mechanisms of cell growth inhibition of hepatocellular carcinoma (HCC) cell lines by the PPARgamma ligand, troglitazone.
Methods: Six HCC cell lines were used to study the effects of troglitazone on cell growth by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay, on cell cycle by flow cytometry, and on the cell cycle-regulating factors of late G1 phase by Western blotting. Apoptosis assays were performed by flow cytometry using membrane, nuclear, cytoplasmic, and mitochondrial markers. Caspase inhibitors were used to analyze the mechanisms of apoptosis induced by troglitazone.
Results: Troglitazone showed a potent dose-dependent effect on the growth inhibition of all six HCC cell lines, which were suppressed to under 50% of control at the concentration of 10 micromol/L. The growth inhibition was linked to the G1 phase cell cycle arrest through the up-expression of the cyclin-dependent kinase inhibitors, p21 and p27 proteins, and the hypophosphorylation of retinoblastoma protein. Troglitazone induced apoptosis by caspase-dependent (mitchondrial transmembrane potential decrease, cleavage of poly [adenosine diphosphate ribose] polymerase, 7A6 antigen exposure, Bcl-2 decrease, and activation of caspase 3) and caspase-independent (phosphatidylserine externalization) mechanisms.
Conclusions: Our data suggest that ligand activation of PPARgamma by troglitazone or modified analogs of the thiazolidinedione class of drugs is a novel target for effective therapy against HCC, because of the significant antiproliferative and programmed cell death induction capabilities demonstrated by troglitazone.
Copyright 2002 American Cancer Society.
Similar articles
- Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
Yu J, Qiao L, Zimmermann L, Ebert MP, Zhang H, Lin W, Röcken C, Malfertheiner P, Farrell GC. Yu J, et al. Hepatology. 2006 Jan;43(1):134-43. doi: 10.1002/hep.20994. Hepatology. 2006. PMID: 16374840 - Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
Koga H, Sakisaka S, Harada M, Takagi T, Hanada S, Taniguchi E, Kawaguchi T, Sasatomi K, Kimura R, Hashimoto O, Ueno T, Yano H, Kojiro M, Sata M. Koga H, et al. Hepatology. 2001 May;33(5):1087-97. doi: 10.1053/jhep.2001.24024. Hepatology. 2001. PMID: 11343236 - [Relationship between peroxisome proliferator activator-receptor (PPAR) and urological cancer].
Yoshimura R, Nakatani T. Yoshimura R, et al. Nihon Rinsho. 2005 Apr;63(4):672-8. Nihon Rinsho. 2005. PMID: 15828236 Review. Japanese. - Peroxisome proliferator-activated receptor gamma (PPargamma) as a novel target for prostate cancer.
Smith MR, Kantoff PW. Smith MR, et al. Invest New Drugs. 2002 May;20(2):195-200. doi: 10.1023/a:1015670126203. Invest New Drugs. 2002. PMID: 12099579 Review.
Cited by
- Turkish coffee has an antitumor effect on breast cancer cells in vitro and in vivo.
Amin MN, Abdelmohsen UR, Samra YA. Amin MN, et al. Nutr Metab (Lond). 2024 Sep 13;21(1):73. doi: 10.1186/s12986-024-00846-4. Nutr Metab (Lond). 2024. PMID: 39272080 Free PMC article. - Crosstalk between gut microbiota and antidiabetic drug action.
Kyriachenko Y, Falalyeyeva T, Korotkyi O, Molochek N, Kobyliak N. Kyriachenko Y, et al. World J Diabetes. 2019 Mar 15;10(3):154-168. doi: 10.4239/wjd.v10.i3.154. World J Diabetes. 2019. PMID: 30891151 Free PMC article. Review. - In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer.
Fujita M, Hasegawa A, Yamamori M, Okamura N. Fujita M, et al. J Exp Clin Cancer Res. 2017 Jul 3;36(1):91. doi: 10.1186/s13046-017-0557-6. J Exp Clin Cancer Res. 2017. PMID: 28673319 Free PMC article. - PPARγ activation by troglitazone enhances human lung cancer cells to TRAIL-induced apoptosis via autophagy flux.
Nazim UM, Moon JH, Lee YJ, Seol JW, Park SY. Nazim UM, et al. Oncotarget. 2017 Apr 18;8(16):26819-26831. doi: 10.18632/oncotarget.15819. Oncotarget. 2017. PMID: 28460464 Free PMC article. - MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers.
Portius D, Sobolewski C, Foti M. Portius D, et al. PPAR Res. 2017;2017:7058424. doi: 10.1155/2017/7058424. Epub 2017 Jan 12. PPAR Res. 2017. PMID: 28167956 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous